Integra LifeSciences Corp.

Company Overview

Integra LifeSciences is a major player in the field of regenerative tissue technologies and neurological solutions. The company is committed to reducing uncertainty for healthcare professionals so that they can prioritize delivering optimal patient care. Established in 1989 with the acquisition of an engineered collagen technology platform designed for tissue repair and regeneration, Integra has developed a diverse range of product lines serving various applications, from addressing burn injuries and deep tissue wounds to repairing the dura mater in the brain, as well as nerves and tendons. The company has broadened its core regenerative technology portfolio to encompass surgical instruments, neurosurgical products and advanced wound care, and it has achieved this through global acquisitions and innovative product development, all aimed at meeting the evolving demands of its customer base and enhancing patient care.

The company operates and sells medical technologies and products through two primary business segments: Codman Specialty Surgical (“CSS”) and Tissue Technologies (“TT”). The CSS segment, contributing to approximately two-thirds of the total revenue, encompasses leading-edge technologies and instruments utilized across various medical specialties, including neurosurgery, neurocritical care and otolaryngology. In the realm of neurosurgery, Integra stands as a world leader and ranks among the top three providers of instruments for precision, specialty and general surgical procedures. The TT segment, accounting for roughly one-third of the overall revenue, concentrates on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair.

Integra maintains key manufacturing and research facilities located in several regions, including California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland. Most of the handheld surgical instruments and dural sealant products are sourced through specialized third-party vendors.

Financial Highlights (FY 2023)

Company's Business Segments

• Codman Specialty Surgical : Technologies and instrumentation used for a wide range of specialties such as Neurosurgery Neurocritical care and Otolaryngology
• Tissue Technologies : Complex wound surgery, Surgical reconstruction, Peripheral nerve repair